NAACCR Item #3894: Multigene Signature Method
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3,894 | 1 | NAACCR |
NAACCR XML: Tumor.multigeneSignatureMethod
Description
Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the likelihood of future metastasis. This data item identifies the multigene signature method used. Oncotype Dx is coded elsewhere.
Rationale
Multigene Signature Method is a Registry Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #22. See also Multigene Signature Results.
Codes
| 1 | Mammaprint |
| 2 | PAM50 (Prosigna) |
| 3 | Breast Cancer Index |
| 4 | EndoPredict |
| 5 | Test performed, type of test unknown |
| 6 | Multiple tests, any tests in codes 1-4 |
| 7 | Test ordered, results not in chart |
| 8 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error.) |
| 9 | Not documented in medical record Multigene Signature Method not assessed or unknown if assessed |
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.